A community-led, harm-reduction approach to chemsex: case study from Australia’s largest gay city
Authors:
- 29 March 2018
- journal article
- research article
- Published by CSIRO Publishing in Sexual Health
- Vol. 15 (2) , 179-181
Abstract
Rates of drug use remain substantially higher among gay and bisexual men (GBM) and people living with HIV (PLHIV) in Sydney, New South Wales, Australia. The use of drugs to enhance sexual pleasure within cultures of Party and Play creates opportunities to discuss sexual health, mental health, consent and wellbeing. Community organisations with a history of HIV prevention, care, treatment are well-placed to respond. ACON’s (formerly the AIDS Council of New South Wales) multi-dimensional response to ‘chemsex’ includes: direct client services support for individuals seeking to manage or reduce their use; health promotion activities that support peer education; partnerships with research institutions to better understand cultures of chemsex; and policy submissions that call for drug use to be approached as a health, rather than a criminal, issue. The approach speaks the language of Party and Play subcultures; employs culturally relevant terminology and imagery; uses content designed, created and delivered by peers; and operates within a pleasure-positive, harm-reduction and community-led framework. These interventions have led to increased service uptake, strong community engagement, robust research partnerships and the recognition of GBM as a priority population in relevant strategies.Keywords
This publication has 4 references indexed in Scilit:
- Methamphetamine treatment outcomes among gay men attending a LGBTI-specific treatment service in Sydney, AustraliaPLOS ONE, 2017
- The future of drugs: recreational drug use and sexual health among gay and other men who have sex with menSexual Health, 2016
- Drugs, Space, and Sociality in a Gay Nightclub in SydneyJournal of Contemporary Ethnography, 2004
- ‘Crystal meth’ use among polydrug users in Sydney's dance party subculture: characteristics, use patterns and associated harmsInternational Journal of Drug Policy, 2003